[go: up one dir, main page]

Matta et al., 2016 - Google Patents

Expansion of regulatory T cells in vitro and in vivo by IL-33

Matta et al., 2016

View PDF
Document ID
173974600789568933
Author
Matta B
Turnquist H
Publication year
Publication venue
Suppression and Regulation of Immune Responses: Methods and Protocols, Volume II

External Links

Snippet

Thymic-derived, regulatory T cells (Treg) represent a subset of CD4+ T cells that are required for normal immune homeostasis and suppression of unwanted responses against self-antigens (Ags) that prevent autoimmunity. Their role as immune regulators and potent …
Continue reading at drive.google.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells

Similar Documents

Publication Publication Date Title
Matta et al. Expansion of regulatory T cells in vitro and in vivo by IL-33
Wu et al. Ablation of transcription factor IRF4 promotes transplant acceptance by driving allogenic CD4+ T cell dysfunction
Yang et al. CD4+ T-cell differentiation in vitro
Flaherty et al. Mouse naive CD4+ T cell isolation and in vitro differentiation into T cell subsets
Qu et al. The effect of immunosuppressive drug rapamycin on regulatory CD4+ CD25+ Foxp3+ T cells in mice
Weist et al. The role of CD4+ T cells in BKV-specific T cell immunity
De Calisto et al. T-cell homing to the gut mucosa: general concepts and methodological considerations
Passos et al. Activation of human CD11b+ B1 B-cells by Trypanosoma cruzi-derived proteins is associated with protective immune response in human Chagas disease
Miyara et al. Combination of IL-2, rapamycin, DNA methyltransferase and histone deacetylase inhibitors for the expansion of human regulatory T cells
RU2627445C2 (en) METHODS FOR IDENTIFICATION, SELECTION, ENRICHMENT AND DEPLETION OF Tr1 CELLS POPULATIONS, Tr1 CELLS POPULATIONS, PHARMACEUTICAL COMPOSITIONS, METHODS FOR THERAPY EFFECT MONITORING
Zhao et al. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease
US20240398695A1 (en) Methods of T Cell Expansion and Activation
Ribeiro et al. Development of a flow cytometry-based potency assay for measuring the in vitro immunomodulatory properties of mesenchymal stromal cells
Haribhai et al. Immunotherapy with iTreg and nTreg cells in a murine model of inflammatory bowel disease
Streeck et al. Rapid ex vivo isolation and long-term culture of human Th17 cells
Stankiewicz et al. Sex-biased human thymic architecture guides T cell development through spatially defined niches
Mensink et al. Tregs from human blood differentiate into nonlymphoid tissue–resident effector cells upon TNFR2 costimulation
Karlsson et al. Ex vivo generation of regulatory T cells: characterization and therapeutic evaluation in a model of chronic colitis
Lorentz et al. Isolation and characterization of human intestinal mast cells
Tabares et al. Short‐term cytokine stimulation reveals regulatory T cells with down‐regulated Foxp3 expression in human peripheral blood
Jin et al. Large-scale in vitro expansion of human regulatory T cells with potent xenoantigen-specific suppression
Jonuleit et al. Regulatory T-Cells in Antitumor Therapy Isolation and Functional Testing of CD4+ CD25+ Regulatory T-Cells
McMurchy et al. In vitro generation of human T regulatory cells: generation, culture, and analysis of FOXP3-transduced T cells
Chesneau et al. New method for the expansion of highly purified human regulatory granzyme B-expressing B cells
Ménoret et al. Phenotypic and Functional Characterization of CD8+ T Regulatory Cells